OS Therapies IncorporatedOSTXNYSE
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank15
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P15
Within normal range
vs 3Y Ago
-1.2x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q3 2025-51.64%
Q2 2025-17.02%
Q1 2025-29.61%
Q4 2024-4.03%
Q3 2024-84.61%
Q2 2024-6.75%
Q1 20240.38%
Q4 202325.84%
Q3 2023-78740.12%
Q2 2023-35.63%
Q1 202327.63%
Q4 20220.00%
Q1 202242.28%
Q4 20210.00%